NCT03644680View on ClinicalTrials.gov

Changes in Adaptive Immune Responses and Effector Cell Responses Upon Nasal Allergen Exposure - a Pilot Study

NACompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

September 24, 2018

Primary Completion Date

October 4, 2019

Study Completion Date

October 4, 2019

Conditions
Allergic RhinitisAllergic Inflammation
Interventions
DIAGNOSTIC_TEST

Nasal Provocation with Birch Extract

Nasal spray containing birch extract from Allergopharma

OTHER

Nasal Provocation with NaCl 0.9%

Nasal spray containing sterile sodium chloride 0.9%

Trial Locations (1)

1090

8H1.02, ENT Lab, Department of Otorhinolaryngology, Vienna General Hospital, Vienna

All Listed Sponsors
lead

Medical University of Vienna

OTHER

NCT03644680 - Changes in Adaptive Immune Responses and Effector Cell Responses Upon Nasal Allergen Exposure - a Pilot Study | Biotech Hunter | Biotech Hunter